Discovery of 4<i>H</i>-Chromen-4-one Derivatives as a New Class of Selective Rho Kinase (ROCK) Inhibitors, which Showed Potent Activity in ex Vivo Diabetic Retinopathy Models.

Citation: Zhao L, Li Y, Wang Y, Qiao Z, Miao Z, Yang J, Huang L, Tian C, Li L, Chen D, Yang S.: Discovery of 4<i>H</i>-Chromen-4-one Derivatives as a New Class of Selective Rho Kinase (ROCK) Inhibitors, which Showed Potent Activity in ex Vivo Diabetic Retinopathy Models. J Med Chem, Volume 62 (23), 2019
Authors: Chen D, Huang L, Li L, Li Y, Miao Z, Qiao Z, Tian C, Wang Y, Yang J, Yang S., Zhao L
Journal: J Med Chem
Year: 2019
DOI: 10.1021/acs.jmedchem.9b01143
PubMed: 31693351
Machine-readable: REST API RDF

Publication